Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Medication management for people with dementia in primary care: description of implementation in the DelpHi study.

Fiß T, Thyrian JR, Wucherer D, Aßmann G, Kilimann I, Teipel SJ, Hoffmann W.

BMC Geriatr. 2013 Nov 13;13:121. doi: 10.1186/1471-2318-13-121.

3.

Dementia care management: going new ways in ambulant dementia care within a GP-based randomized controlled intervention trial.

Eichler T, Thyrian JR, Dreier A, Wucherer D, Köhler L, Fiß T, Böwing G, Michalowsky B, Hoffmann W.

Int Psychogeriatr. 2014 Feb;26(2):247-56. doi: 10.1017/S1041610213001786. Epub 2013 Oct 23.

4.

Effects of a three party healthcare network on the incidence levels of drug related problems.

Fiß T, Meinke-Franze C, van den Berg N, Hoffmann W.

Int J Clin Pharm. 2013 Oct;35(5):763-71. doi: 10.1007/s11096-013-9804-x. Epub 2013 Jul 14.

PMID:
23851929
5.

Prevalence and determinants of controlled hypertension in a German population cohort.

van den Berg N, Meinke-Franze C, Fiss T, Baumeister SE, Hoffmann W.

BMC Public Health. 2013 Jun 19;13:594. doi: 10.1186/1471-2458-13-594.

6.

Changes in blood pressure in patients with hypertension in the context of delegated GP-home visits: a prospective implementation study.

van den Berg N, Meinke-Franze C, Fiss T, Hoffmann W.

Blood Press Monit. 2013 Apr;18(2):63-71. doi: 10.1097/MBP.0b013e32835d1002.

PMID:
23324878
7.

Life- and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): study protocol for a randomised controlled trial.

Thyrian JR, Fiß T, Dreier A, Böwing G, Angelow A, Lueke S, Teipel S, Fleßa S, Grabe HJ, Freyberger HJ, Hoffmann W.

Trials. 2012 May 10;13:56. doi: 10.1186/1745-6215-13-56.

8.

Cognitive impairment in primary ambulatory health care: pharmacotherapy and the use of potentially inappropriate medicine.

Fiss T, Thyrian JR, Fendrich K, van den Berg N, Hoffmann W.

Int J Geriatr Psychiatry. 2013 Feb;28(2):173-81. doi: 10.1002/gps.3806. Epub 2012 Apr 16.

PMID:
22505357
9.

[Medication review for dementia patients].

Jahns KP, Kilimann I, Ritter CA, Hoffmann W, Teipel SJ, Fiss T.

Med Monatsschr Pharm. 2012 Mar;35(3):95-103. Review. German.

PMID:
22452126
10.

Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs--results of the home medication review in the AGnES-studies.

Hoffmann W, van den Berg N, Thyrian JR, Fiss T.

Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1311-8. doi: 10.1002/pds.2224. Epub 2011 Sep 15.

PMID:
21919114
11.

[Time required and associated costs for implementation of home medication review with associated pharmaceutical and medical evaluation in the ambulatory health care sector].

Fiß T, Schaefer M, van den Berg N, Hoffmann W.

Gesundheitswesen. 2012 May;74(5):322-7. doi: 10.1055/s-0031-1275716. Epub 2011 May 11. German.

PMID:
21563050
12.

Correspondence (letter to the editor):Definition of age.

Fiss T, Hoffmann W.

Dtsch Arztebl Int. 2010 Dec;107(50):899-900. doi: 10.3238/arztebl.2010.0899b. Epub 2010 Dec 17. No abstract available.

13.

Frequency of inappropriate drugs in primary care: analysis of a sample of immobile patients who received periodic home visits.

Fiss T, Dreier A, Meinke C, van den Berg N, Ritter CA, Hoffmann W.

Age Ageing. 2011 Jan;40(1):66-73. doi: 10.1093/ageing/afq106. Epub 2010 Sep 7.

PMID:
20823125
14.

Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany.

Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W.

Pharm World Sci. 2010 Oct;32(5):566-74. doi: 10.1007/s11096-010-9409-6. Epub 2010 Jul 1.

PMID:
20593238
15.

AGnES: supporting general practitioners with qualified medical practice personnel: model project evaluation regarding quality and acceptance.

van den Berg N, Meinke C, Heymann R, Fiss T, Suckert E, Pöller C, Dreier A, Hoffmann W, Rogalski H, Oppermann R, Karopka T.

Dtsch Arztebl Int. 2009 Jan;106(1-2):3-9. doi: 10.3238/arztebl.2009.0003. Epub 2009 Jan 5.

16.

GP-support by means of AGnES-practice assistants and the use of telecare devices in a sparsely populated region in Northern Germany--proof of concept.

van den Berg N, Fiss T, Meinke C, Heymann R, Scriba S, Hoffmann W.

BMC Fam Pract. 2009 Jun 19;10:44. doi: 10.1186/1471-2296-10-44.

17.

Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.

Hoffmann W, Herzog B, Mühlig S, Kayser H, Fabian R, Thomsen M, Cramer M, Fiss T, Gresselmeyer D, Janhsen K.

Ann Pharmacother. 2008 Dec;42(12):1804-13. doi: 10.1345/aph.1K635. Epub 2008 Nov 11.

PMID:
19001531
18.

Christos Stavros Papastavros, M.D.

Fiss T.

Del Med J. 1999 Feb;71(2):89-91. No abstract available.

PMID:
10079596
19.

Mesenteric mast cell degranulation is not essential for conditioned taste aversion.

Persinger MA, Fiss TB.

Pharmacol Biochem Behav. 1978 Dec;9(6):725-30.

PMID:
746046
20.

Perforated viscus presenting with gas in the soft tissues (subcutaneous emphysema).

Fiss TW, Cigtay OS, Miele AJ, Twigg HL.

Am J Roentgenol Radium Ther Nucl Med. 1975 Sep;125(1):226-33.

PMID:
1200213

Supplemental Content

Loading ...
Support Center